苏达皮里丁 (WX-081) 通过向ATP合成酶和上调宿主天生的免疫力来抑制Mycobacterium结核病
Xinda Li1,2, Xiaoyi Luo1,2, Bin Wang1,2
1Department of Pharmacology, Beijing Chest Hospital, Capital Medical University, Beijing, China.
mSphere
|May 21, 2025
概括
WX-081通过向ATP合成酶和增强宿主免疫力,对抗耐药结核病具有双重作用. 这种更安全的贝达奎林替代品为消除结核病提供了一个有希望的新战略.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 药物发现 药物发现 药物发现
背景情况:
- 耐药结核病 (DR-TB) 需要替代贝达基林 (BDQ),因为毒性和耐药性.
- WX-081是一个有前途的下一代BDQ替代品,具有更好的安全性和有效性.
- 了解WX-081的机制对于优化其治疗潜力至关重要.
研究的目的:
- 为了阐明WX-081对抗DR-TB的分子机制.
- 为了研究WX-081对宿主免疫反应的影响.
- 为了验证WX-081作为一种潜在的抗结核剂.
主要方法:
- 抗药性查和基因测序以确定药物标.
- 功能性测试以评估ATP合成酶抑制和质子动力干扰.
- 巨细胞转录学和分子对接,以探索免疫调节和结合部位.
主要成果:
- WX-081针对atpE基因,破坏细菌ATP合成和质子动力.
- 分子对接证实了ATPE内的特定结合点.
- WX-081通过激活NF-κB和MAPK通路来增强宿主免疫力.
结论:
- WX-081表现出双重的作用机制:直接的抗微生物活性和宿主免疫增强.
- 这些发现支持WX-081作为治疗DR-TB的有效和安全候选人.
- 需要进一步的研究来充分描述其治疗特性.
相关概念视频
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.5K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
506
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
506
Antihypertensive Drugs: Thiazide-Class Diuretics
484
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
484
Desensitization and Tachyphylaxis
1.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.4K
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
324
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
324
Enzyme Inhibition
77.7K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
77.7K


